Improving efficiency in clinical trials using auxiliary information: Application of a multi‐state cure model

DOI10.1111/BIOM.12281MaRDI QIDQ3459944zbMATH OpenOpenAlexWikidataFDO

Authors A. S. C. Conlon, Daniel J. Sargent, Jeremy M. G. Taylor

Publication date 11 January 2016

Published in Biometrics (Search for Journal in Brave)

Full work available at URL http://europepmc.org/articles/pmc4480062

zbMATH Keywords

multiple imputationauxiliary variablemulti-state modelcure modelscolon cancerKaplan-Meier estimates

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Estimation in multivariate analysis (62H12)

Recommendations

• Improving Efficiency of Inferences in Randomized Clinical Trials Using Auxiliary Covariates
• scientific article; zbMATH DE number 2135398
• Approaches for Optimal Sequential Decision Analysis in Clinical Trials
• Bayesian design of clinical trials using joint cure rate models for longitudinal and time-to-event data
• Stochastic approximation and modern model-based designs for dose-finding clinical trials
• Using pilot study information to increase efficiency in clinical trials

Cites work

• scientific article; zbMATH DE number 2140075 (Why is no real title available?)
• scientific article; zbMATH DE number 775726 (Why is no real title available?)
• A Measure of the Proportion of Treatment Effect Explained by a Surrogate Marker
• A shrinkage approach for estimating a treatment effect using intermediate biomarker data in clinical trials
• Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
• Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials
• Multiple Imputation After 18+ Years
• Some comments on efficiency gains from auxiliary information for right-censored data
• Using Auxiliary Variables for Improved Estimates of Survival Time
• Using surrogate failure time data to increase cost effectiveness in clinical trials

Cited in

(3)

• A note on compatibility for inference with missing data in the presence of auxiliary covariates
• A Bayesian multi‐risks survival (MRS) model in the presence of double censorings
• Using categorical markers as auxiliary variables in log-rank tests and hazard ratio estimation

This page was built for publication: Improving efficiency in clinical trials using auxiliary information: Application of a multi‐state cure model

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3459944)